Abstract
Abnormal fibroblasts have been implicated in keloid formation, a benign but fibroproliferative skin disorder. However, the exact source of these cells remains unknown. Fibrocytes are considered to be hybrid mesenchymal/hematopoietic cells, having been identified in various fibrotic disorders as the precursors of fibroblasts. Therefore, we hypothesized that a population of fibrocytes is present in keloid tissue as opposed to the mesenchymal stem cells (MSCs). We compared the proportion of MSCs in keloid versus bone marrow-derived cells and compared fibrocytes in keloid as opposed to normal scar tissue. We also investigated the propagation of fibrocytes in serum-supplemented versus serum-free media. Using multicolor fluorescence-activated cell analysis, we found distinct populations of MSCs (CD34−CD73+CD90+CD105+) that were different from CD45RO+25F9+MRP8/14+ fibrocytes present in keloid tissue, while very few fibrocytes were observed in normal scar tissue. The proportion of keloid-derived cells in serum-free or serum-supplemented cultures expressing these fibrocyte markers was greater than from cultures derived from normal scar tissue (p < 0.05). We found that the proliferation of CD45+/Col1+ keloid cells in vitro was greater in serum-free media compared to serum-supplemented media. This is the first study to have identified fibrocytes isolated from keloid tissue and normal scars, utilizing a specific set of markers for fibrocytes. This finding may aid our understanding of the origin of abnormal fibroblasts identified in keloid scarring. The identification of fibrocyte populations distinct from MSCs in keloid scar tissue could lead to novel targets for therapeutic intervention, treatment and prevention of recurrence.
This is a preview of subscription content, log in via an institution to check access.
References
Barisic-Dujmovic T, Boban I, Clark SH (2010) Fibroblasts/myofibroblasts that participate in cutaneous wound healing are not derived from circulating progenitor cells. J Cell Physiol 222:703–712
Bucala R, Spiegel LA, Chesney J et al (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71–81
Dienus K, Bayat A, Gilmore BF et al (2010) Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option. Arch Dermatol Res 302:725–731
Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317
Forbes SJ, Russo FP, Rey V et al (2004) A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126:955–963
Iqbal SA, Manning C, Syed F et al (2011) Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren’s disease: a potential source of myofibroblasts with implications for pathogenesis and therapy. Stem Cells Dev 21(4):609–622
Iqbal SA, Syed F, Mcgrouther DA et al (2010) Differential distribution of haematopoietic and nonhaematopoietic progenitor cells in intralesional and extralesional keloid: do keloid scars provide a niche for nonhaematopoietic mesenchymal stem cells? Br J Dermatol 162:1377–1383
James WD, Besanceney CD, Odom RB (1980) The ultrastructure of a keloid. J Am Acad Dermatol 3:50–57
Mori L, Bellini A, Stacey MA et al (2005) Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 304:81–90
Ogawa M, Larue AC, Drake CJ (2006) Hematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications. Blood 108:2893–2896
Pilling D, Buckley CD, Salmon M et al (2003) Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 171:5537–5546
Pilling D, Fan T, Huang D et al (2009) Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 4:e7475
Santucci M, Borgognoni L, Reali UM et al (2001) Keloids and hypertrophic scars of Caucasians show distinctive morphologic and immunophenotypic profiles. Virchows Arch 438:457–463
Shih B, Bayat A (2011) Comparative genomic hybridisation analysis of keloid tissue in Caucasians suggests possible involvement of HLA-DRB5 in disease pathogenesis. Arch Dermatol Res
Shih B, Bayat A (2010) Genetics of keloid scarring. Arch Dermatol Res 302:319–339
Shih B, Garside E, Mcgrouther DA et al (2010) Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen 18:139–153
Strieter RM, Keeley EC, Hughes MA et al (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol 86:1111–1118
Yang L, Scott PG, Dodd C et al (2005) Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 13:398–404
Acknowledgments
The corresponding author (AB) received funding from the National Institute for Health Research (NIHR), UK.
Conflict of interest
The authors state no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iqbal, S.A., Sidgwick, G.P. & Bayat, A. Identification of fibrocytes from mesenchymal stem cells in keloid tissue: a potential source of abnormal fibroblasts in keloid scarring. Arch Dermatol Res 304, 665–671 (2012). https://doi.org/10.1007/s00403-012-1225-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-012-1225-5